300358 Truking Technology
- 7.85
- +0.04+0.51%
Truking Technology News
Chutian Technology (300358): Steady revenue growth in 2023
Chutian Technology (300358): Bioengineering leads growth, price competition intensifies short-term pressure on performance
Analysis of listing pricing of Chutian Convertible Bonds
Chutian Technology (300358): The industrial chain is gradually improving, and we look forward to innovation and breaking the game
Chutian Technology (300358): The rapid growth of bioengineering industry chain layout continues to be implemented
Chutian Technology (300358): External factors influence Q3 performance under pressure, and it is expected that it will gradually recover in 24
Chutian Technology (300358): Revenue side is growing steadily, profit side is being dragged down by market competition
Chutian Technology (300358): Revenue side is growing steadily, profit side is being dragged down by market competition
Chutian Technology (300358) Company Incident Review Report: Overseas Market Performance Remarkable, Front-end Biotech Sector Development Resilience Continues to Increase
Chutian Technology (300358): Revenue side growth is steady, bioengineering and other sectors are growing at impressive rates
Chutian Technology (300358): Revenue scale is growing steadily and diversified business development continues to be promoted
Chutian Technology (300358) 2023H1 review: Revenue is growing steadily and profitability is expected to pick up
Chutian Technology (300358): Revenue increased steadily in the first half of the year and continued expansion of new products
Chutian Technology (300358): The performance is basically in line with expectations, and the competitiveness of the bioengineering sector continues to improve
Chutian Technology (300358): Steady growth in revenue scale and further deepening of industrial chain layout
Research Report Nuggets 丨 Guoxin Securities: Chutian Technology's revenue side is growing well, and new product development has made a breakthrough
Chutian Technology (300358) 2022 Annual Report and 2023 Quarterly Report Reviews: The results of bioengineering layout are beginning to show that annual performance is expected to maintain steady growth
Chutian Technology (300358): Rapid revenue growth in 2022
Chutian Technology (300358): After excluding the influence of incentives, Q3 revenue and profit all achieved rapid growth
Chutian Technology (300358): Revenue increased 25.81% year-on-year in the third quarter alone and gradually entered platform-based development
Analysis
Price Target
No Data
